Treatment of patients with HCV infection with or without liver biopsy
- 20 October 2004
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 11 (6) , 536-542
- https://doi.org/10.1111/j.1365-2893.2004.00519.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseJournal of Hepatology, 2002
- To the Editor:Hepatology, 2001
- The Role of Liver Biopsy in Chronic Hepatitis CHepatology, 2001
- Epidemiology and long term prognosis of hepatitis C virus infection in Japan.Gut, 1993
- The Pathology of Hepatitis CHepatology, 1992
- Our Stubborn Quest for Diagnostic CertaintyNew England Journal of Medicine, 1989
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986
- Derived ThresholdsMedical Decision Making, 1983
- Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosisDigestive Diseases and Sciences, 1983
- The Threshold Approach to Clinical Decision MakingNew England Journal of Medicine, 1980